Keyword

PG545

Description: PG545 is an investigational heparan sulfate mimetic that inhibits heparanase and angiogenesis, studied as an anticancer agent.
OpenAlex ID: keywords/pg545
2015 · Anna Shteingauz, Ilanit Boyango, et al. · Cancer Research · 160
2012 · Vito Ferro, Ligong Liu, et al. · Journal of Medicinal Chemistry · 148
2022 · Scott E. Guimond, Courtney J. Mycroft-West, et al. · ACS Central Science · 121
2018 · Keith Dredge, Todd V. Brennan, et al. · British Journal of Cancer · 107
2013 · Katherine T. Ostapoff, Niranjan Awasthi, et al. · Molecular Cancer Therapeutics · 75
2015 · Todd V. Brennan, Liwen Lin, et al. · Journal of Clinical Investigation · 73
2014 · Ilanit Boyango, Uri Barash, et al. · Cancer Research · 72
2018 · Uri Barash, Moshe Lapidot, et al. · JNCI Journal of the National Cancer Institute · 59
2020 · Mohit Chhabra, Vito Ferro · Advances in experimental medicine and biology · 54
2018 · Marina Weissmann, Udayan Bhattacharya, et al. · Matrix Biology · 50
2019 · Naphak Modhiran, Neha S. Gandhi, et al. · Antiviral Research · 45
2022 · Mohit Chhabra, Jennifer C. Wilson, et al. · Chemistry - A European Journal · 29
2011 · Anna Lundin, Tomas Bergström, et al. · Antiviral Research · 29
2018 · Aroon Supramaniam, Xiang Liu, et al. · Antimicrobial Agents and Chemotherapy · 27
Works count: 96
Citation count: 2,076
Year
Topic
Type